<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although childhood <z:hpo ids='HP_0006721'>acute lymphoblastic leukemias</z:hpo> are of good prognosis than <z:hpo ids='HP_0001909'>leukemias</z:hpo> of adulthood, some chromosomal abnormalities may have negative effects on their prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>Inverted duplication (1q) is a chromosomal abnormality with negative effect on outcome of Burkitt <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of CD20 Burkitt <z:hpo ids='HP_0001909'>leukemia</z:hpo> with inverted duplication (1q) mutation, who had an early relapse during NHL-BFM 95 treatment </plain></SENT>
<SENT sid="3" pm="."><plain>Two courses of ICE-rituximab treatment were administered after relapse and a successful HLA-full match bone marrow transplantation was carried out </plain></SENT>
<SENT sid="4" pm="."><plain>He is in follow-up for 18 months without any problem after the bone marrow transplantation </plain></SENT>
<SENT sid="5" pm="."><plain>We suggest the usage of ICE protocol combined with rituximab in childhood CD20 Burkitt <z:hpo ids='HP_0001909'>leukemia</z:hpo> with poor prognostic criteria such as inverted duplication (1q) mutation </plain></SENT>
</text></document>